The Epidermal Growth Factor Receptor (EGFR) overexpression is recognized as a driver mechanism in the initiation, progression, and therapy resistance of several carcinomas such as lung, breast, and pancreatic cancers [44], added the interaction HOXB7/EGFR promoter region already demonstrated [25]. Here, EGFR is linked to pancreatic neoplasm.